< Back to previous page

Project

Targeting the chromatin for innovative cancer therapy.

Changes in the chromatin environment (mutations, translocations, epigenetic changes) are initiating factors of uncontrolled cell growth/oncogenesis. Chroma Target wishes to develop new, more specific therapeutic strategies (with minor side effects) and lead compounds against a subset of cancers with poor prognosis from an improved understanding of the malignant chromatin environment. Comparing omica data will also enable personalized medicine through identification of specific biomarkers.

Date:1 Nov 2014 →  31 Oct 2018
Keywords:oncogenese, Chroma Target, cancer therapy, chromatin
Disciplines:Microbiology, Systems biology, Laboratory medicine